CAR-NK therapy: an effective strategy for cancer treatment

Written by Sino Biological
Cancer research Drug discovery and development Immunology

CAR-NK therapy involves the modification of natural killer (NK) cells with mature chimeric antigen receptor (CAR) technology to exploit their unique target cell recognition mechanism and broad tumor-killing ability.

In this Application Note, experts from Sino Biological introduce the CAR-NK therapeutic strategy, which has numerous advantages to enhance overall safety and reduce antigenic escape failure.

CAR-NK Therapy-An Effective Strategy for Cancer Treatment

This content was provided by

Follow Sino Biological on Twitter, Facebook and on LinkedIn.

 

Submit Your Research to the F1000Research Oncology Gateway

Share your oncology research with the global scientific community through the F1000Research Oncology Gateway. With trusted publishing, open access, and transparent peer review, your work will uphold the highest standards of research integrity while driving innovation in cancer treatment and understanding.

Join a trusted platform that accelerates progress in oncology. Submit your research today at F1000Research Oncology Gateway.